FindTrial
Sign In

Establishment of cohort for management of Parkinson's disease

Establishment of cohort for management of Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006293
Enrollment
800
Registered
2021-06-24
Start date
2021-07-19
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor
Korea Disease Control and Prevention Agency
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Parkinson's disease patients who are diagnosed based on the UK Parkinson’s Disease Society Brain Bank criteria, and Movement Disorder Society criteria.

Exclusion criteria

Exclusion criteria: Atypical Parkinsonism and secondary Parkinsonism

Design outcomes

Primary

MeasureTime frame
Unified Parkinson’s Disease Rating Scale (Movement Disorder Society);Hoehn and Yahr stage;Nonmotor symptom scale;Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT);Parkinson's disease sleep scale 2;REM sleep behavior disorder screening questionnaire;Epworth Sleepiness Score;Montgomery-Asberg Depression Rating Scale (MADRS);Minimental status examination II;Clinical Dementia Rating;Seoul Neuropsychiatric Screening Battery;Orthostatic blood pressure change;Parkinson's Disease Questionnaire (PDQ-39);Caregiver burden inventory—

Secondary

MeasureTime frame
The regional standardized uptake value ratios (SUVRs) of 18F-N-(3-fluoropropyl)-2beta-carbon ethoxy-3beta-(4-iodophenyl) nortropane (18F-FP-CIT)—

Countries

Korea, Republic of

Contacts

Public ContactJoong-Seok Kim

The Catholic University of Korea, Seoul St. Mary's Hospital

neuronet@catholic.ac.kr+82-2-2258-6078

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026